Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests - Wall Street Journal

Bristol-Myers, Alder To Pursue Rheumatoid Arthritis Drug Tests Wall Street Journal (BMY) and Alder Biopharmaceuticals Inc. said they will continue developing a possible treatment for rheumatoid arthritis based on new data from a Phase II ... New Data for Investigational Antibody Blocking IL-6 in Rheumatoid Arthritis ...MarketWatch (press release) Bristol-Myers says arthritis drug trial met goalReuters BMY Candidate Meets Study GoalZacks.com Pharmacy Europe all 112 news articles »

Pfizer Cuts Off Arthritis Drug - Forbes

Pfizer Cuts Off Arthritis Drug Forbes Trubion Pharmaceuticals said late Monday that Pfizer had decided to discontinue development of one of the two investigational rheumatoid arthritis drugs on ... Pfizer Focuses, Investors Should CheerMotley Fool Pfizer pulls plug on arthritis studyTheDay.com (blog) Trubion: Pfizer cancels rheumatoid arthritis drugBusinessWeek Xconomy -Reuters -BioWorld Online all 48 news articles »

Almost three quarters of women with rheumatoid arthritis worldwide suffer pain ... - EurekAlert (press release)

Almost three quarters of women with rheumatoid arthritis worldwide suffer pain ... EurekAlert (press release) Rome, Italy, Wednesday 16 June 2010: Almost three quarters (72%) of women with Rheumatoid Arthritis (RA) suffer pain daily, despite the fact that three ... NHS launches new osteoarthritis toolCraegmoor News More alcohol may result in less arthritisiTWire all 14 news articles »

NATURE Publishes New Dynavax Findings on Novel Role of TLRs in Lupus - MarketWatch (press release)

NATURE Publishes New Dynavax Findings on Novel Role of TLRs in Lupus MarketWatch (press release) ... IFN-alpha and also reduce symptoms in multiple autoimmune disease animal models, such as lupus, inflammatory skin disorders, and rheumatoid arthritis. ... and more »